SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sugen (SUGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Phillipa who wrote (123)1/2/1998 5:52:00 PM
From: Miljenko Zuanic  Read Replies (1) of 550
 
Anyone here:

IMO, Company significantly increase SU101 proprietary position with two new patents, still last minute tax-sell continue. Patent issue is not eliminated, but picture is now more rosy than without this patents. Also, SU 101 (with multiple mode of action and one of its is PDGF-R1 antagonist) posses weak Flt/KDR antagonist property.

Any news on side effects profile from on-going clinical trials?

Thanks.

mz
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News